#BEGIN_DRUGCARD DB02761

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
5652-32-4

# ChEBI_ID:
28839

# Chemical_Formula:
C3H7NO2S2

# Chemical_IUPAC_Name:
(2R)-2-amino-3-disulfanylpropanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
S-Mercaptocysteine

# HET_ID:
CSS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H7NO2S2/c4-2(1-8-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1

# InChI_Key:
InChIKey=XBKONSCREBSMCS-REOHCLBHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01962

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2761

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
153.223

# Molecular_Weight_Mono:
152.991819853

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GN9

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2

# Predicted_LogS:
-1

# Predicted_Water_Solubility:
1.43e+01 g/l

# Primary_Accession_No:
DB02761

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
165331

# PubChem_Substance_ID:
46505635

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01038

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CSS)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:27 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Cytoplasm

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AB055108

# Drug_Target_10_GenBank_ID_Protein:
12619308

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
sufS

# Drug_Target_10_Gene_Sequence:
>1221 bp
ATGATTTTTTCCGTCGACAAAGTGCGGGCCGACTTTCCGGTGCTTTCGCGTGAGGTAAAC
GGTTTGCCGCTGGCTTATCTCGACAGCGCCGCCAGTGCGCAGAAACCGAGCCAGGTGATT
GACGCCGAGGCCGAGTTTTATCGTCATGGCTACGCGGCGGTGCATCGTGGTATTCATACC
TTAAGCGCCCAGGCGACCGAGAAAATGGAGAACGTGCGCAAGCGGGCATCGCTGTTTATT
AATGCCCGTTCGGCGGAAGAGCTGGTGTTCGTCCGCGGCACGACGGAAGGGATCAATCTG
GTCGCCAATAGCTGGGGCAACAGCAACGTGCGGGCGGGCGATAACATCATCATCAGTCAG
ATGGAGCACCACGCTAACATTGTTCCCTGGCAGATGCTTTGCGCACGCGTTGGCGCAGAG
CTGCGTGTGATCCCGCTCAATCCCGATGGTACGTTGCAACTGGAGACGCTGCCTACGCTG
TTTGATGAGAAAACTCGCCTGCTGGCAATTACTCATGTCTCCAACGTGCTTGGCACAGAA
AATCCACTGGCGGAAATGATCACGCTTGCGCACCAGCATGGCGCAAAAGTGCTGGTGGAT
GGCGCTCAGGCGGTGATGCATCATCCGGTGGATGTTCAGGCGCTGGATTGCGACTTTTAC
GTGTTCTCCGGGCATAAACTGTATGGCCCCACCGGAATTGGCATTCTTTATGTGAAAGAA
GCCTTGTTGCAGGAGATGCCGCCGTGGGAAGGGGGCGGTTCTATGATCGCCACCGTCAGC
CTGAGTGAAGGCACTACCTGGACCAAAGCACCATGGCGGTTTGAAGCCGGTACACCCAAT
ACCGGGGGCATCATTGGTCTTGGCGCGGCGCTGGAGTATGTTTCGGCGCTGGGGCTTAAT
AACATAGCCGAGTATGAACAGAATCTGATGCATTATGCGCTATCACAGCTGGAATCTGTA
CCGGATCTCACTCTCTATGGCCCACAAAACAGGCTTGGCGTTATTGCTTTTAATCTCGGT
AAACACCACGCCTATGATGTTGGCAGTTTTCTCGATAATTACGGCATTGCTGTGCGTACC
GGACATCACTGCGCAATGCCATTGATGGCCTATTACAACGTCCCTGCGATGTGTCGGGCG
TCGCTGGCCATGTATAACACCCATGAAGAAGTGGATCGTCTGGTGACCGGCCTGCAACGT
ATTCACCGTTTGCTGGGATAA

# Drug_Target_10_General_Function:
Amino acid transport and metabolism

# Drug_Target_10_General_References:
10322040	Patzer SI, Hantke K: SufS is a NifS-like protein, and SufD is necessary for stability of the [2Fe-2S] FhuF protein in Escherichia coli. J Bacteriol. 1999 May;181(10):3307-9.
10329673	Mihara H, Maeda M, Fujii T, Kurihara T, Hata Y, Esaki N: A nifS-like gene, csdB, encodes an Escherichia coli counterpart of mammalian selenocysteine lyase. Gene cloning, purification, characterization and preliminary x-ray crystallographic studies. J Biol Chem. 1999 May 21;274(21):14768-72.
10684605	Fujii T, Maeda M, Mihara H, Kurihara T, Esaki N, Hata Y: Structure of a NifS homologue: X-ray structure analysis of CsdB, an Escherichia coli counterpart of mammalian selenocysteine lyase. Biochemistry. 2000 Feb 15;39(6):1263-73.
10739946	Mihara H, Kurihara T, Yoshimura T, Esaki N: Kinetic and mutational studies of three NifS homologs from Escherichia coli: mechanistic difference between L-cysteine desulfurase and L-selenocysteine lyase reactions. J Biochem (Tokyo). 2000 Apr;127(4):559-67.
10829016	Lacourciere GM, Mihara H, Kurihara T, Esaki N, Stadtman TC: Escherichia coli NifS-like proteins provide selenium in the pathway for the biosynthesis of selenophosphate. J Biol Chem. 2000 Aug 4;275(31):23769-73.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
2748

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
44434

# Drug_Target_10_Name:
Cysteine desulfurase

# Drug_Target_10_Number_of_Residues:
406

# Drug_Target_10_PDB_ID:
1I29

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00266	Aminotran_5

# Drug_Target_10_Protein_Sequence:
>Cysteine desulfurase
MIFSVDKVRADFPVLSREVNGLPLAYLDSAASAQKPSQVIDAEAEFYRHGYAAVHRGIHT
LSAQATEKMENVRKRASLFINARSAEELVFVRGTTEGINLVANSWGNSNVRAGDNIIISQ
MEHHANIVPWQMLCARVGAELRVIPLNPDGTLQLETLPTLFDEKTRLLAITHVSNVLGTE
NPLAEMITLAHQHGAKVLVDGAQAVMHHPVDVQALDCDFYVFSGHKLYGPTGIGILYVKE
ALLQEMPPWEGGGSMIATVSLSEGTTWTKAPWRFEAGTPNTGGIIGLGAALEYVSALGLN
NIAEYEQNLMHYALSQLESVPDLTLYGPQNRLGVIAFNLGKHHAYDVGSFLDNYGIAVRT
GHHCAMPLMAYYNVPAMCRASLAMYNTHEEVDRLVTGLQRIHRLLG

# Drug_Target_10_Reaction:
L-cysteine + [enzyme]-cysteine = L-alanine + [enzyme]-S-sulfanylcysteine ALL_REAC (other) R07460

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Cysteine desulfurases mobilize the sulfur from L- cysteine to yield L-alanine, an essential step in sulfur metabolism for biosynthesis of a variety of sulfur-containing biomolecules. Component of the suf operon, which is activated and required under specific conditions such as oxidative stress and iron limitation. Acts as a potent selenocysteine lyase in vitro, that mobilizes selenium from L-selenocysteine. Selenocysteine lyase activity is however unsure in vivo

# Drug_Target_10_SwissProt_ID:
P77444

# Drug_Target_10_SwissProt_Name:
SUFS_ECOLI

# Drug_Target_10_Synonyms:
EC 2.8.1.7
EC 4.4.1.16
SCL
Selenocysteine beta-lyase
Selenocysteine lyase
Selenocysteine reductase

# Drug_Target_10_Theoretical_pI:
6.32

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AJ313201

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
MST

# Drug_Target_1_Gene_Sequence:
>1113 bp
ATGTCTGCTCCTGCTGCTGCGCCGAAACACCCGGGCAAGGTGTTCCTGGACCCGAGCGAG
GTAAAGGACCACCTTGCTGAGTACCGCATCGTGGACTGCCGGTACAGCTTGAAGATAAAG
GACCACGGCAGCATCCAGTACGCGAAGGAGCACGTGAAGAGCGCCATCCGCGCCGATGTG
GATACGAACCTCTCTAAGTTGGTGCCCACCAGCACCGCCCGGCATCCGCTACCGCCCTGT
GCTGAGTTTATCGACTGGTGCATGGCGAACGGGATGGCGGGAGAGCTGCCAGTGCTCTGC
TACGATGACGAGTGCGGCGCCATGGGTGGATGCCGCCTGTGGTGGATGCTGAACTCTCTT
GGCGCCGACGCGTACGTGATCAACGGCGGCTTTCAGGCCTGCAAGGCTGCGGGGCTGGAG
ATGGAGTCCGGCGAGCCCTCGTCGCTGCCAAGACCCGCAACGCACTGGCCCTTCAAGACG
GCCTTTCAGCATCACTACCTTGTGGATGAAATCCCGCCCAACGCAATCATCACCGACGCG
CGCTCCGCCGACCGCTTCGCCTCGACAGTACGACCTTACGCCGCAGACAAGATGCCAGGC
CACATCGAAGGTGCGCGTAACCTCCCCTACACGTCGCACCTCGTGACACGCGGTGACGGC
AAGGTGCTGCGCAGTGAGGAAGAGATCCGCCACAACATCATGACCGTCGTGCAAGGCGCG
GGTGACGCGGCTGATCTATCGAGCTTCGTCTTCTCCTGCGGCAGCGGCGTCACCGCCTGC
ATCAATATCGCCCTGGTGCACCACCTCGGCCTGGGCCATCCGTACCTCTACTGTGGCTCC
TGGTCTGAGTACAGCGGCCTCTTCCGCCCCCCCATAATGCGCAGCATCATCGACGACTAC
GGCATGTGCATGCAAATGCAGACCCCTAGCCTCGGCGACAACCCGAAGGCAAACCTCGAC
ACCATGACGCTGAAGGTCGACGGCGCGCCCTGCGAGAGACCCGATGCGGAGGTGCAGAGC
GCCGCAACCCACCTCCACGCTGGCGAGGCCGCTACCGTGTACTTCAAGAGCGGCCGCGTC
GTCACGATCGAGGTGCCGGCAGTGCCCAACTAA

# Drug_Target_1_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4134

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
40155

# Drug_Target_1_Name:
Mercaptopyruvate sulfurtransferase

# Drug_Target_1_Number_of_Residues:
370

# Drug_Target_1_PDB_ID:
1OKG

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Mercaptopyruvate sulfurtransferase
MSAPAAAPKHPGKVFLDPSEVKDHLAEYRIVDCRYSLKIKDHGSIQYAKEHVKSAIRADV
DTNLSKLVPTSTARHPLPPCAEFIDWCMANGMAGELPVLCYDDECGAMGGCRLWWMLNSL
GADAYVINGGFQACKAAGLEMESGEPSSLPRPATHWPFKTAFQHHYLVDEIPPNAIITDA
RSADRFASTVRPYAADKMPGHIEGARNLPYTSHLVTRGDGKVLRSEEEIRHNIMTVVQGA
GDAADLSSFVFSCGSGVTACINIALVHHLGLGHPYLYCGSWSEYSGLFRPPIMRSIIDDY
GMCMQMQTPSLGDNPKANLDTMTLKVDGAPCERPDAEVQSAATHLHAGEAATVYFKSGRV
VTIEVPAVPN

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q7K9G0

# Drug_Target_1_SwissProt_Name:
Q7K9G0_LEIMA

# Drug_Target_1_Synonyms:
EC 2.8.1.2

# Drug_Target_1_Theoretical_pI:
6.29

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M80336

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
dtxR

# Drug_Target_2_Gene_Sequence:
>681 bp
ATGAAGGACTTAGTCGATACCACAGAGATGTACTTGCGCACTATCTATGAGCTGGAAGAA
GAGGGAGTCACTCCCCTTCGCGCTAGGATCGCCGAGCGTCTGGAACAATCTGGACCTACA
GTTAGCCAAACCGTTGCCCGTATGGAGCGCGATGGACTTGTCGTTGTCGCCTCAGACCGT
AGTCTACAAATGACGCCAACAGGTCGTACGTTAGCGACTGCAGTCATGCGTAAGCATCGC
TTAGCAGAGCGCCTTCTTACCGATATCATTGGCCTAGATATCAATAAAGTTCACGATGAA
GCCTGCCGATGGGAACATGTCATGAGCGACGAAGTTGAGCGCAGGCTCGTGAAAGTGCTG
AAAGATGTCAGCAGGTCCCCCTTCGGAAACCCGATTCCAGGGCTTGACGAACTAGGCGTA
GGTAATTCCGACGCGGCAGCCCCCGGAACTCGCGTCATCGATGCTGCCACAAGCATGCCC
CGCAAAGTACGCGTTGTTCAGATAAATGAAATCTTCCAAGCTGAAACGGATCAATTCACG
CAGCTCCTCGACGCTGATATCCGTGTCGGTACAGAAGTCGAAATCGTGGATAGAGACGGG
CATATCACGTTGCGCCACAATGGAAAAGATGTCGAACTGTACGATGATCTGACTCACACT
ATCCGTATCGAAGAACTCTAA

# Drug_Target_2_General_Function:
Involved in iron ion binding

# Drug_Target_2_General_References:
10085021	Goranson-Siekierke J, Pohl E, Hol WG, Holmes RK: Anion-coordinating residues at binding site 1 are essential for the biological activity of the diphtheria toxin repressor. Infect Immun. 1999 Apr;67(4):1806-11.
1400485	Tao X, Murphy JR: Binding of the metalloregulatory protein DtxR to the diphtheria tox operator requires a divalent heavy metal ion and protects the palindromic sequence from DNase I digestion. J Biol Chem. 1992 Oct 25;267(30):21761-4.
14602910	Cerdeno-Tarraga AM, Efstratiou A, Dover LG, Holden MT, Pallen M, Bentley SD, Besra GS, Churcher C, James KD, De Zoysa A, Chillingworth T, Cronin A, Dowd L, Feltwell T, Hamlin N, Holroyd S, Jagels K, Moule S, Quail MA, Rabbinowitsch E, Rutherford KM, Thomson NR, Unwin L, Whitehead S, Barrell BG, Parkhill J: The complete genome sequence and analysis of Corynebacterium diphtheriae NCTC13129. Nucleic Acids Res. 2003 Nov 15;31(22):6516-23.
1502169	Schmitt MP, Twiddy EM, Holmes RK: Purification and characterization of the diphtheria toxin repressor. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7576-80.
1735717	Boyd JM, Hall KC, Murphy JR: DNA sequences and characterization of dtxR alleles from Corynebacterium diphtheriae PW8(-), 1030(-), and C7hm723(-). J Bacteriol. 1992 Feb;174(4):1268-72.
2116013	Boyd J, Oza MN, Murphy JR: Molecular cloning and DNA sequence analysis of a diphtheria tox iron-dependent regulatory element (dtxR) from Corynebacterium diphtheriae. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5968-72.
7568230	Schiering N, Tao X, Zeng H, Murphy JR, Petsko GA, Ringe D: Structures of the apo- and the metal ion-activated forms of the diphtheria tox repressor from Corynebacterium diphtheriae. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9843-50.
8823163	Qiu X, Pohl E, Holmes RK, Hol WG: High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor. Biochemistry. 1996 Sep 24;35(38):12292-302.
9697776	White A, Ding X, vanderSpek JC, Murphy JR, Ringe D: Structure of the metal-ion-activated diphtheria toxin repressor/tox operator complex. Nature. 1998 Jul 30;394(6692):502-6.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4801

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
25344

# Drug_Target_2_Name:
Diphtheria toxin repressor

# Drug_Target_2_Number_of_Residues:
226

# Drug_Target_2_PDB_ID:
2DTR

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01325	Fe_dep_repress
PF02742	Fe_dep_repr_C
PF04023	FeoA

# Drug_Target_2_Protein_Sequence:
>Diphtheria toxin repressor
MKDLVDTTEMYLRTIYELEEEGVTPLRARIAERLEQSGPTVSQTVARMERDGLVVVASDR
SLQMTPTGRTLATAVMRKHRLAERLLTDIIGLDINKVHDEACRWEHVMSDEVERRLVKVL
KDVSRSPFGNPIPGLDELGVGNSDAAVPGTRVIDAATSMPRKVRIVQINEIFQVETDQFT
QLLDADIRVGSEVEIVDRDGHITLSHNGKDVELIDDLAHTIRIEEL

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Iron-binding repressor of the dipheteria toxin gene expression. May serve as a global regulator of gene expression. Represses ripA under iron excess

# Drug_Target_2_SwissProt_ID:
P33120

# Drug_Target_2_SwissProt_Name:
DTXR_CORDI

# Drug_Target_2_Synonyms:
Iron-dependent diphtheria tox regulatory element
Tox regulatory factor

# Drug_Target_2_Theoretical_pI:
4.69

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AF061964

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
c-des

# Drug_Target_3_Gene_Sequence:
>1182 bp
ATGGCTGACCCTGTGAACCTAATACCCGATCGCCACCAATTTCCTGGCCTAGCCAATAAG
ACCTATTTTAATTTTGGCGGCCAGGGTATTTTGCCCACCGTTGCCCTGGAAGCTATTACG
GCTATGTATGGCTATCTACAGGAAAATGGCCCTTTTTCCATTGCCGCTAATCAACATATT
CAGCAGTTAATTGCCCAACTACGGCAGGCTTTGGCGGAAACTTTTAACGTTGATCCCAAC
ACAATTACAATCACCGATAACGTCACCACCGGCTGTGACATTGTGCTTTGGGGTTTGGAT
TGGCACCAGGGCGATGAAATTTTGCTCACCGACTGCGAACATCCCGGCATCATTGCCATT
GTCCAGGCGATCGCCGCCCGGTTTGGCATTACCTACCGTTTTTTCCCGGTGGCGGCCACG
TTAAACCAGGGAGATGCGGCCGCAGTGTTGGCTAATCATCTGGGGCCAAAAACCCGCTTG
GTTATTCTCAGTCATTTACTCTGGAACACTGGCCAAGTATTGCCCCTAGCAGAAATTATG
GCCGTTTGTCGCCGTCACCAAGGAAATTATCCAGTGCGGGTTTTAGTGGATGGGGCCCAA
TCTGCCGGTTCCTTACCCCTAGATTTTTCCCGGTTAGAAGTGGATTATTATGCTTTCACC
GGCCATAAATGGTTTGCTGGCCCCGCTGGGGTGGGGGGATTGTATATCCATGGCGATTGC
CTGGGGGAAATTAATCCGACCTATGTGGGTTGGCGCAGTATCACCTATGGCGCTAAAGGG
GAACCCACCGGCTGGGCTGAAGGGGGCAAACGGTTTGAAGTGGCCACCTCCGCCTATCCC
CAATATGCCGGTCTGTTGGCCGCTCTCCAGTTGCACCAACGGCAAGGCACCGCTGAGGAA
CGTTACCAAGCCATTTGTCAACGTAGTGAATTCCTGTGGCGGGGCTTGAACCAGTTACCC
CATGTCCATTGTTTAGCTACATCGGCTCCCCAAGCAGGTTTGGTCTCCTTCACCGTGGAT
TCTCCCTTGGGCCACCGGGCGATCGTGCAGAAACTGGAGGAGCAACGCATCTATCTCCGT
ACCATCGCTGACCCTGACTGTATCCGGGCCTGTTGCCATTACATAACCGATGAGGAGGAA
ATTAATCATTTATTGGCTAGACTAGCTGACTTTGGCCCCTAA

# Drug_Target_3_General_Function:
Involved in transaminase activity

# Drug_Target_3_General_References:
9099686	Leibrecht I, Kessler D: A novel L-cysteine/cystine C-S-lyase directing [2Fe-2S] cluster formation of Synechocystis ferredoxin. J Biol Chem. 1997 Apr 18;272(16):10442-7.
9867829	Lang T, Kessler D: Evidence for cysteine persulfide as reaction product of L-Cyst(e)ine C-S-lyase (C-DES) from Synechocystis. Analyses using cystine analogues and recombinant C-DES. J Biol Chem. 1999 Jan 1;274(1):189-95.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
4802

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
43155

# Drug_Target_3_Name:
L-cysteine/cystine lyase C-DES

# Drug_Target_3_Number_of_Residues:
393

# Drug_Target_3_PDB_ID:
1N31

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00266	Aminotran_5

# Drug_Target_3_Protein_Sequence:
>L-cysteine/cystine lyase C-DES
MADPVNLIPDRHQFPGLANKTYFNFGGQGILPTVALEAITAMYGYLQENGPFSIAANQHI
QQLIAQLRQALAETFNVDPNTITITDNVTTGCDIVLWGLDWHQGDEILLTDCEHPGIIAI
VQAIAARFGITYRFFPVAATLNQGDAAAVLANHLGPKTRLVILSHLLWNTGQVLPLAEIM
AVCRRHQGNYPVRVLVDGAQSAGSLPLDFSRLEVDYYAFTGHKWFAGPAGVGGLYIHGDC
LGEINPTYVGWRSITYGAKGEPTGWAEGGKRFEVATSAYPQYAGLLAALQLHQRQGTAEE
RYQAICQRSEFLWRGLNQLPHVHCLATSAPQAGLVSFTVDSPLGHRAIVQKLEEQRIYLR
TIADPDCIRACCHYITDEEEINHLLARLADFGP

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
Q9ZHG9

# Drug_Target_3_SwissProt_Name:
Q9ZHG9_SYNY4

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
6.10

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
AP009048

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
sseA

# Drug_Target_4_Gene_Sequence:
>843 bp
TCCACGACATGGTTTGTAGGAGCCGACTGGCTCGCCGAACATATTGATGACCCGGAAATT
CAGATTATCGATGCCCGCATGGCGTCGCCTGGACAGGAGGATCGTAACGTTGCTCAGGAG
TATCTGAATGGACATATTCCCGGCGCAGTGTTTTTTGATATCGAAGCGCTTTCTGATCAC
ACTTCCCCGCTTCCGCACATGCTGCCGCGCCCGGAAACGTTCGCCGTGGCGATGCGTGAA
TTAGGCGTTAACCAGGATAAGCACCTGATTGTCTATGACGAAGGTAATCTTTTCTCAGCC
CCACGAGCATGGTGGATGCTGCGCACCTTTGGTGTAGAGAAAGTGTCGATTCTGGGGGGT
GGACTTGCAGGCTGGCAGCGCGATGATCTGCTGTTAGAAGAAGGTGCAGTAGAGCTGCCG
GAAGGAGAGTTTAACGCCGCGTTTAATCCTGAAGCCGTGGTGAAAGTAACCGATGTATTA
TTGGCAAGCCATGAAAATACGGCGCAAATTATTGATGCCCGCCCGGCTGCACGTTTTAAC
GCAGAAGTTGATGAACCTCGCCCAGGTTTACGTCGCGGACATATTCCCGGAGCACTGAAT
GTTCCGTGGACGGAACTGGTGCGCGAAGGCGAACTAAAAACGACCGATGAACTGGATGCG
ATATTTTTTGGTCGCGGCGTCAGCTACGACAAACCAATTATCGTCAGCTGCGGCTCTGGT
GTAACGGCAGCCGTGGTTTTGTTAGCACTCGCGACGCTGGATGTGCCAAACGTGAAACTG
TACGACGGCGCATGGAGTGAATGGGGCGCGCGGGCAGATTTACCGGTTGAGCCAGTGAAA
TAA

# Drug_Target_4_General_Function:
Involved in thiosulfate sulfurtransferase activity

# Drug_Target_4_General_References:
11445076	Colnaghi R, Cassinelli G, Drummond M, Forlani F, Pagani S: Properties of the Escherichia coli rhodanese-like protein SseA: contribution of the active-site residue Ser240 to sulfur donor recognition. FEBS Lett. 2001 Jul 6;500(3):153-6.
7982894	Hama H, Kayahara T, Ogawa W, Tsuda M, Tsuchiya T: Enhancement of serine-sensitivity by a gene encoding rhodanese-like protein in Escherichia coli. J Biochem. 1994 Jun;115(6):1135-40.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
4803

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
30812

# Drug_Target_4_Name:
3-mercaptopyruvate sulfurtransferase

# Drug_Target_4_Number_of_Residues:
281

# Drug_Target_4_PDB_ID:
1URH

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00581	Rhodanese

# Drug_Target_4_Protein_Sequence:
>3-mercaptopyruvate sulfurtransferase
MSTTWFVGADWLAEHIDDPEIQIIDARMASPGQEDRNVAQEYLNGHIPGAVFFDIEALSD
HTSPLPHMLPRPETFAVAMRELGVNQDKHLIVYDEGNLFSAPRAWWMLRTFGVEKVSILG
GGLAGWQRDDLLLEEGAVELPEGEFNAAFNPEAVVKVTDVLLASHENTAQIIDARPAARF
NAEVDEPRPGLRRGHIPGALNVPWTELVREGELKTTDELDAIFFGRGVSYDKPIIVSCGS
GVTAAVVLLALATLDVPNVKLYDGAWSEWGARADLPVEPVK

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Transfers a sulfur ion to cyanide or to other thiol compounds. Also has weak rhodanese activity (130-fold lower). Its participation in detoxification of cyanide may be small. May be involved in the enhancement of serine sensitivity

# Drug_Target_4_SwissProt_ID:
P31142

# Drug_Target_4_SwissProt_Name:
THTM_ECOLI

# Drug_Target_4_Synonyms:
EC 2.8.1.2
MST
Rhodanese-like protein

# Drug_Target_4_Theoretical_pI:
4.30

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasm

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Z11707

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
hcp

# Drug_Target_5_Gene_Sequence:
>1662 bp
ATGTTTTGCTTCCAGTGTCAGGAAACAGCGAAGAATACGGGATGCACGGTCAAAGGTATG
TGCGGCAAGCCGGAAGAAACCGCCAATTTGCAGGATCTGCTCATTTTTGTGCTGCGTGGC
ATCGCCATTTATGGCGAAAAATTAAAGGAGTTGGGACAGCCGGACCGCTCTAATGACGAC
TTCGTGCTCCAGGGATTATTTGCGACCATCACCAATGCTAACTGGGATGATGCCCGATTT
GAGGCTATGATATCGGAAGGCTTGGCTCGGCGTGACAAGTTGAGAAATGCTTTTCTGGCT
GTTTACAAGGCAAAAAATGGCAAAGATTTCAGCGAGCCGTTGCCCGAAGCCGCGACTTGG
ACTGGGGACTCTACCGCTTTTGCTGAAAAGGCCAAGAGCGTAGGCATTCTGGCAACTGAG
AACGAAGATGTGCGTTCTTTGCGCGAACTGCTCATAATCGGTCTGAAAGGTGTCGCGGCC
TATGCCGAGCACGCTGCTGTACTGGGCTTTCGCAAGACCGAAATCGACGAATTCATGCTT
GAGGCCCTGGCTTCAACGACCAAGGATTTGTCCGTGGATGAAATGGTCGCGCTGGTCATG
AAGGCCGGCGGCATGGCCGTAACCACCATGGCCCTGCTGGACGAGGCCAACACCACTACC
TACGGCAACCCGGAAATCACCCAGGTCAACATCGGCGTGGGCAAGAACCCCGGCATCCTC
ATCAGCGGCCATGACCTGAAGGATATGGCCGAGTTGCTGAAGCAGACCGAGGGCACAGGC
GTGGACGTTTACACCCACGGCGAAATGCTTCCCGCCAACTATTATCCGGCGTTCAAGAAG
TACCCGCATTTCGTGGGGAACTACGGCGGTTCCTGGTGGCAGCAGAATCCCGAATTCGAG
TCCTTCAACGGCCCCATCCTGCTGACCACAAACTGTCTGGTGCCGCTCAAAAAAGAGAAC
ACCTATCTGGACCGTCTCTACACCACTGGCGTGGTTGGGTATGAAGGGGCCAAGCACATC
GCTGACCGGCCTGCGGGAGGAGCCAAGGATTTCTCGGCGCTGATCGCACAGGCCAAGAAA
TGTCCTCCGCCCGTTGAGATCGAGACTGGTAGCATCGTCGGCGGTTTCGCCCATCATCAG
GTACTAGCCTTGGCCGACAAGGTGGTTGAGGCTGTCAAGTCCGGCGCGATCAAGCGCTTT
GTGGTCATGGCCGGGTGTGACGGTCGGCAGAAGTCTCGTTCCTATTACACTGAAGTGGCC
GAAAATTTGCCCAAGGACACCGTGATCTTGACGGCCGGTTGCGCCAAGTACCGCTATAAC
AAACTGAATCTCGGTGACATCGGTGGCATTCCACGTGTGCTGGACGCAGGGCAGTGCAAC
GATTCCTATTCCCTGGCCGTCATTGCTCTGAAACTCAAAGAAGTCTTCGGCCTGGATGAC
ATCAACGATCTGCCCGTATCTTACGATATCGCCTGGTACGAGCAGAAGGCCGTGGCCGTG
CTTCTGGCCCTCCTATTCTTAGGTGTGAAGGGAATCCGCCTCGGACCCACGCTTCCGGCA
TTCCTGTCCCCGAACGTGGCCAAGGTACTGGTTGAAAATTTCAACATCAAACCAATCGGA
ACAGTGCAGGATGACATCGCGGCCATGATGGCGGGTAAATAG

# Drug_Target_5_General_Function:
Involved in oxidoreductase activity, acting on other nitrogenous compounds as donors

# Drug_Target_5_General_References:
11106482	Cooper SJ, Garner CD, Hagen WR, Lindley PF, Bailey S: Hybrid-cluster protein (HCP) from Desulfovibrio vulgaris (Hildenborough) at 1.6 A resolution. Biochemistry. 2000 Dec 12;39(49):15044-54.
11941509	Macedo S, Mitchell EP, Romao CV, Cooper SJ, Coelho R, Liu MY, Xavier AV, LeGall J, Bailey S, Garner DC, Hagen WR, Teixeira M, Carrondo MA, Lindley P: Hybrid cluster proteins (HCPs) from Desulfovibrio desulfuricans ATCC 27774 and Desulfovibrio vulgaris (Hildenborough): X-ray structures at 1.25 A resolution using synchrotron radiation. J Biol Inorg Chem. 2002 Apr;7(4-5):514-25. Epub 2002 Jan 23.
12764602	Aragao D, Macedo S, Mitchell EP, Romao CV, Liu MY, Frazao C, Saraiva LM, Xavier AV, LeGall J, van Dongen WM, Hagen WR, Teixeira M, Carrondo MA, Lindley P: Reduced hybrid cluster proteins (HCP) from Desulfovibrio desulfuricans ATCC 27774 and Desulfovibrio vulgaris (Hildenborough): X-ray structures at high resolution using synchrotron radiation. J Biol Inorg Chem. 2003 May;8(5):540-8. Epub 2003 Feb 15.
1318832	Pierik AJ, Wolbert RB, Mutsaers PH, Hagen WR, Veeger C: Purification and biochemical characterization of a putative [6Fe-6S] prismane-cluster-containing protein from Desulfovibrio vulgaris (Hildenborough). Eur J Biochem. 1992 Jun 15;206(3):697-704.
1318833	Pierik AJ, Hagen WR, Dunham WR, Sands RH: Multi-frequency EPR and high-resolution Mossbauer spectroscopy of a putative [6Fe-6S] prismane-cluster-containing protein from Desulfovibrio vulgaris (Hildenborough). Characterization of a supercluster and superspin model protein. Eur J Biochem. 1992 Jun 15;206(3):705-19.
1339351	Stokkermans JP, Pierik AJ, Wolbert RB, Hagen WR, Van Dongen WM, Veeger C: The primary structure of a protein containing a putative [6Fe-6S] prismane cluster from Desulfovibrio vulgaris (Hildenborough). Eur J Biochem. 1992 Sep 1;208(2):435-42.
9492318	Krockel M, Trautwein AX, Arendsen AF, Hagen WR: The prismane protein resolved--Mossbauer investigation of a 4Fe cluster with an unusual mixture of bridging ligands and metal coordinations. Eur J Biochem. 1998 Jan 15;251(1-2):454-61.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4804

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
59980

# Drug_Target_5_Name:
Hydroxylamine reductase

# Drug_Target_5_Number_of_Residues:
553

# Drug_Target_5_PDB_ID:
1OA1

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF03063	Prismane

# Drug_Target_5_Protein_Sequence:
>Hydroxylamine reductase
MFCFQCQETAKNTGCTVKGMCGKPEETANLQDLLIFVLRGIAIYGEKLKELGQPDRSNDD
FVLQGLFATITNANWDDARFEAMISEGLARRDKLRNAFLAVYKAKNGKDFSEPLPEAATW
TGDSTAFAEKAKSVGILATENEDVRSLRELLIIGLKGVAAYAEHAAVLGFRKTEIDEFML
EALASTTKDLSVDEMVALVMKAGGMAVTTMALLDEANTTTYGNPEITQVNIGVGKNPGIL
ISGHDLKDMAELLKQTEGTGVDVYTHGEMLPANYYPAFKKYPHFVGNYGGSWWQQNPEFE
SFNGPILLTTNCLVPLKKENTYLDRLYTTGVVGYEGAKHIADRPAGGAKDFSALIAQAKK
CPPPVEIETGSIVGGFAHHQVLALADKVVEAVKSGAIKRFVVMAGCDGRQKSRSYYTEVA
ENLPKDTVILTAGCAKYRYNKLNLGDIGGIPRVLDAGQCNDSYSLAVIALKLKEVFGLDD
INDLPVSYDIAWYEQKAVAVLLALLFLGVKGIRLGPTLPAFLSPNVAKVLVENFNIKPIG
TVQDDIAAMMAGK

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Catalyzes the reduction of hydroxylamine to form NH(3) and H(2)O (By similarity)

# Drug_Target_5_SwissProt_ID:
P31101

# Drug_Target_5_SwissProt_Name:
HCP_DESVH

# Drug_Target_5_Synonyms:
EC 1.7.-.-
HCP
Hybrid-cluster protein
Prismane protein

# Drug_Target_5_Theoretical_pI:
5.29

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
Not Available

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
TST

# Drug_Target_6_Gene_Sequence:
Not Available

# Drug_Target_6_General_Function:
Not Available

# Drug_Target_6_General_References:
Not Available

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6965

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
Not Available

# Drug_Target_6_Name:
Thiosulfate sulfurtransferase

# Drug_Target_6_Number_of_Residues:
0

# Drug_Target_6_PDB_ID:
Not Available

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
Not Available

# Drug_Target_6_Protein_Sequence:
Not Available

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
Not Available

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q16762

# Drug_Target_6_SwissProt_Name:
THTR_HUMAN

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
Not Available

# Drug_Target_6_Transmembrane_Regions:
Not Available

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AP008226

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
TTHA1028

# Drug_Target_7_Gene_Sequence:
>858 bp
ATGGGGTACGCCCATCCCGAGGTTTTGGTGAGCACCGACTGGGTCCAGGAGCACCTGGAG
GACCCCAAGGTACGGGTCCTCGAGGTGGACGAGGACATCCTCCTCTACGACACCGGGCAC
ATCCCGGGGGCCCAGAAGATTGACTGGCAGCGGGACTTCTGGGACCCGGTGGTCCGGGAC
TTCATCAGCGAGGAGGAGTTCGCCAAGCTCATGGAAAGGCTCGGCATCTCCAACGACACC
ACCGTGGTCCTCTACGGGGACAAGAACAACTGGTGGGCCGCCTACGCCTTCTGGTTCTTC
AAGTACAACGGCCACAAGGACGTGCGGCTCATGAACGGCGGGCGGCAAAAGTGGGTGGAG
GAAGGCCGCCCCCTCACCACCGAGGTCCCCTCCTACCCCCCGGGGCGCTACGAGGTCCCC
TACCGGGACGAGTCCATCCGGGCCTACCGGGACGACGTCCTGGAGCACATCATCAAGGTG
AAGGAAGGCAAGGGCGCCCTGGTGGACGTGCGTAGCCCCCAGGAGTACCGCGGGGAGCTC
ACCCACATGCCCGACTACCCCCAGGAGGGGGCCCTCCGCGCCGGCCACATCCCCGGGGCG
AAGAACATCCCCTGGGCCAAAGCGGTGAACCCCGACGGCACCTTCAAAAGCGCCGAGGAG
CTCCGGGCCCTCTACGAGCCTCTCGGGATCACCAAAGACAAGGACATCGTCGTCTACTGC
CGCATCGCCGAGCGGTCCAGCCACTCCTGGTTCGTCCTCAAGTACCTCCTGGGCTACCCC
CACGTGAAGAACTACGACGGCTCCTGGACCGAGTGGGGCAACCTGGTGGGGGTGCCCATC
GCCAAAGGCGAGGAGTAG

# Drug_Target_7_General_Function:
Involved in thiosulfate sulfurtransferase activity

# Drug_Target_7_General_References:
Not Available

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
4806

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
32925

# Drug_Target_7_Name:
Thiosulfate sulfurtransferase

# Drug_Target_7_Number_of_Residues:
285

# Drug_Target_7_PDB_ID:
1UAR

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00581	Rhodanese

# Drug_Target_7_Protein_Sequence:
>Thiosulfate sulfurtransferase
MGYAHPEVLVSTDWVQEHLEDPKVRVLEVDEDILLYDTGHIPGAQKIDWQRDFWDPVVRD
FISEEEFAKLMERLGISNDTTVVLYGDKNNWWAAYAFWFFKYNGHKDVRLMNGGRQKWVE
EGRPLTTEVPSYPPGRYEVPYRDESIRAYRDDVLEHIIKVKEGKGALVDVRSPQEYRGEL
THMPDYPQEGALRAGHIPGAKNIPWAKAVNPDGTFKSAEELRALYEPLGITKDKDIVVYC
RIAERSSHSWFVLKYLLGYPHVKNYDGSWTEWGNLVGVPIAKGEE

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not Available

# Drug_Target_7_SwissProt_ID:
Q5SJI0

# Drug_Target_7_SwissProt_Name:
Q5SJI0_THET8

# Drug_Target_7_Synonyms:
Not Available

# Drug_Target_7_Theoretical_pI:
5.14

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasm

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AE005674

# Drug_Target_8_GenBank_ID_Protein:
24053900

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
glpE

# Drug_Target_8_Gene_Sequence:
>264 bp
TTACGCGCCGTACGCCACCTCTGCGGGAAACTGTCGCTGCCAGGCTTCAAAGCCGCCGTC
AATGCTATAGACCACATCGTAGCCCTGTTGCAGCAGATACTGCGCCGCCCCTTTGCTGCT
ATTGCCGTGATAACACATCACCATCACCGGAGTGTCAAAGTCGTTATCACGCATAAACGC
GCCCAGCGTGTCGTTGGTTAAATGGAAAGCCTGCACCGCATGCCCCATAGCGAAACTCTG
TGGATCGCGAATATCGACCAGCAC

# Drug_Target_8_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_8_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
3204

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
12083

# Drug_Target_8_Name:
Thiosulfate sulfurtransferase glpE

# Drug_Target_8_Number_of_Residues:
108

# Drug_Target_8_PDB_ID:
1GN0

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00581	Rhodanese

# Drug_Target_8_Protein_Sequence:
>Thiosulfate sulfurtransferase glpE
MDQFECINVADAHQKLQEKEAVLVDIRDPQSFAMGHAVQAFHLTNDTLGAFMRDNDFDTP
VMVMCYHGNSSKGAAQYLLQQGYDVVYSIDGGFEAWQRQFPAEVAYGA

# Drug_Target_8_Reaction:
thiosulfate + cyanide = sulfite + thiocyanate

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Catalyzes, although with low efficiency, the sulfur transfer reaction from thiosulfate to cyanide

# Drug_Target_8_SwissProt_ID:
P0A6V7

# Drug_Target_8_SwissProt_Name:
GLPE_SHIFL

# Drug_Target_8_Synonyms:
EC 2.8.1.1

# Drug_Target_8_Theoretical_pI:
4.29

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cytoplasm

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
Z11975

# Drug_Target_9_GenBank_ID_Protein:
49286

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
hcp

# Drug_Target_9_Gene_Sequence:
>1638 bp
ATGAGTAATGCCATGTTCTGCTACCAGTGCCAGGAAACCGTGGGTAACAAAGGCTGCACC
CAGGTAGGCGTGTGCGGCAAAAAGCCTGAAACAGCCGCCCTTCAGGACGCGCTGATCTAT
GTGACCAAGGGCCTCGGCCAGATCGCCACGCGCCTGCGCGCCGAAGGCAAGGCCGTTGAC
CACAGGATAGACCGCCTGGTTACCGGCAACCTGTTTGCCACCATCACCAATGCCAACTTT
GACGACGACATCCTTGCCGAGCGTGTGCGCATGACCTGTGCCGCCAAAAAGGAACTGGCC
GCGTCCCTTACCGACAAGAGCGGCCTCAGCGATGCAGCCTTGTGGGAAGCATCCGAAAAG
TCCGCCATGCTGGCCAAGGCCGGAACCGTAGGCGTTATGGCCACCACCGATGATGATGTG
CGCTCCCTGCGCTGGCTCATCACCTTTGGGCTCAAGGGCATGGCGGCCTACGCCAAACAT
GCGGATGTGCTTGGCAAGCATGAAAACAGCCTTGACGCCTTCATGCAGGAAGCCCTTGCC
AAAACCCTGGATGACAGCCTGAGCGTGGCCGACCTTGTGGCCCTGACCCTTGAAACGGGC
AAGTTCGGCGTATCGGCCATGGCCCTGCTGGATGCTGCCAATACCGGTACCTACGGCCAC
CCAGAAATTACCAAGGTCAACATCGGCGTGGGCAGCAATCCCGGCATCCTCATTTCCGGG
CATGACCTGCGCGACCTTGAAATGCTGCTCAAGCAGACCGAAGGCACAGGCGTTGACGTG
TACACCCACTCTGAAATGCTGCCCGCCCATTACTACCCTGCCTTCAAGAAGTACGCGCAC
TTCAAGGGCAACTACGGCAATGCATGGTGGAAACAGAAAGAAGAATTTGAAAGCTTTAAC
GGCCCCGTGCTGCTGACCACCAACTGCCTTGTGCCGCCCAAGGACAGCTACAAGGACCGC
GTGTACACCACCGGCATCGTGGGTTTTACGGGCTGCAAGCATATCCCCGGTGAAATCGGC
GAACACAAGGACTTCAGCGCCATCATCGCCCATGCCAAGACCTGTCCCGCGCCTACGGAA
ATCGAATCCGGCGAAATCATCGGCGGCTTCGCGCACAATCAGGTACTGGCCCTGGCCGAC
AAGGTGATTGACGCGGTCAAATCCGGCGCCATCAAAAAGTTCGTGGTCATGGCCGGCTGC
GACGGCCGCGCCAAGTCCCGCAGCTACTACACCGACTTTGCCGAAGGCCTGCCCAAAGAC
ACGGTCATCCTTACCGCCGGTTGCGCCAAATATCGCTACAACAAGCTCAACCTGGGTGAC
ATCGGCGGCATCCCGCGCGTACTGGACGCCGGGCAGTGCAACGACTCCTACTCCCTGGCC
GTCATCGCCCTCAAGCTCAAGGAAGTATTCGGCCTCGAGGACGTCAACGACCTGCCCATC
GTCTACAATATCGCCTGGTACGAGCAGAAGGCCGTTATCGTGCTGCTGGCCCTGCTGAGC
CTCGGCGTGAAGAATATCCACCTCGGACCGACGCTGCCCGCCTTCCTTTCGCCCAACGTG
GCCAAGGTGCTGGTGGAACAGTTCAACATCGGCGGCATCACCAGTCCGCAGGACGACCTC
AAGGCGTTCTTCGGCTAA

# Drug_Target_9_General_Function:
Energy production and conversion

# Drug_Target_9_General_References:
11941509	Macedo S, Mitchell EP, Romao CV, Cooper SJ, Coelho R, Liu MY, Xavier AV, LeGall J, Bailey S, Garner DC, Hagen WR, Teixeira M, Carrondo MA, Lindley P: Hybrid cluster proteins (HCPs) from Desulfovibrio desulfuricans ATCC 27774 and Desulfovibrio vulgaris (Hildenborough): X-ray structures at 1.25 A resolution using synchrotron radiation. J Biol Inorg Chem. 2002 Apr;7(4-5):514-25. Epub 2002 Jan 23.
12764602	Aragao D, Macedo S, Mitchell EP, Romao CV, Liu MY, Frazao C, Saraiva LM, Xavier AV, LeGall J, van Dongen WM, Hagen WR, Teixeira M, Carrondo MA, Lindley P: Reduced hybrid cluster proteins (HCP) from Desulfovibrio desulfuricans ATCC 27774 and Desulfovibrio vulgaris (Hildenborough): X-ray structures at high resolution using synchrotron radiation. J Biol Inorg Chem. 2003 May;8(5):540-8. Epub 2003 Feb 15.
1311311	Moura I, Tavares P, Moura JJ, Ravi N, Huynh BH, Liu MY, LeGall J: Direct spectroscopic evidence for the presence of a 6Fe cluster in an iron-sulfur protein isolated from Desulfovibrio desulfuricans (ATCC 27774) J Biol Chem. 1992 Mar 5;267(7):4489-96.
1511014	Stokkermans JP, van den Berg WA, van Dongen WM, Veeger C: The primary structure of a protein containing a putative [6Fe-6S] prismane cluster from Desulfovibrio desulfuricans (ATCC 27774). Biochim Biophys Acta. 1992 Aug 17;1132(1):83-7.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
3274

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
58660

# Drug_Target_9_Name:
Hydroxylamine reductase

# Drug_Target_9_Number_of_Residues:
545

# Drug_Target_9_PDB_ID:
1UPX

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF03063	Prismane

# Drug_Target_9_Protein_Sequence:
>Hydroxylamine reductase
MSNAMFCYQCQETVGNKGCTQVGVCGKKPETAALQDALIYVTKGLGQIATRLRAEGKAVD
HRIDRLVTGNLFATITNANFDDDILAERVRMTCAAKKELAASLTDKSGLSDAALWEASEK
SAMLAKAGTVGVMATTDDDVRSLRWLITFGLKGMAAYAKHADVLGKHENSLDAFMQEALA
KTLDDSLSVADLVALTLETGKFGVSAMALLDAANTGTYGHPEITKVNIGVGSNPGILISG
HDLRDLEMLLKQTEGTGVDVYTHSEMLPAHYYPAFKKYAHFKGNYGNAWWKQKEEFESFN
GPVLLTTNCLVPPKDSYKDRVYTTGIVGFTGCKHIPGEIGEHKDFSAIIAHAKTCPAPTE
IESGEIIGGFAHNQVLALADKVIDAVKSGAIKKFVVMAGCDGRAKSRSYYTDFAEGLPKD
TVILTAGCAKYRYNKLNLGDIGGIPRVLDAGQCNDSYSLAVIALKLKEVFGLEDVNDLPI
VYNIAWYEQKAVIVLLALLSLGVKNIHLGPTLPAFLSPNVAKVLVEQFNIGGITSPQDDL
KAFFG

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Catalyzes the reduction of hydroxylamine to form NH(3) and H(2)O

# Drug_Target_9_SwissProt_ID:
Q01770

# Drug_Target_9_SwissProt_Name:
HCP_DESDA

# Drug_Target_9_Synonyms:
EC 1.7.-.-
HCP
Hybrid-cluster protein
Prismane protein

# Drug_Target_9_Theoretical_pI:
6.45

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB02761
